Matinas BioPharma (MTNB)

• Market cap: $3.4M
• 1 day: -3.64%
• 5 days: -14.52%
• 1 month: -14.31%
• 3 months: -14.52%
• 6 months: -72.54%
• Year to date: -14.52%
• 1 year: -5.1%
• 5 years: -99.01%
• 10 years: -99.72%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Employees: 34